February 21, 2025

Study Links Stress to Immune Changes in Breast Cancer

New research shows chronic stressors like perceived stress, inadequate social support, racial discrimination, and neighborhood deprivation are associated with deleterious changes to systemic and tumor immunity in breast cancer patients, with more pronounced effects in Black women.

Conexiant

February 21, 2025

Environmental vs. Genetic Risk in Aging and Mortality

Researchers quantify the exposome's greater impact on aging and mortality risk compared with genetic predisposition, identifying 25 key environmental risk factors.

Conexiant

February 21, 2025

Jennifer A. Woyach, MD, Named The Ohio State’s Director of Hematology

Jennifer A. Woyach, MD, a hematology cancer expert and researcher who has been with The Ohio State for more than 12 years, has been named Director of the Division of Hematology at The Ohio State Unive...

The ASCO Post

February 21, 2025

Exercise Therapy as Candidate Anticancer Strategy

Lee Jones, PhD, Head of the Exercise Oncology Program at Memorial Sloan Kettering Cancer Center, shared findings from an early-phase clinical trial to determine the feasibility, safety, and tumor biol...

The ASCO Post

February 21, 2025

Former UNMC Cancer Center Director, Kenneth H. Cowan, MD, PhD, Dies at 77

Kenneth H. Cowan, MD, PhD, served for 24 years as Director of the National Cancer Institute (NCI)-designated cancer center at the University of Nebraska Medical Center (UNMC), now called the Nebraska ...

The ASCO Post

February 21, 2025

FDA Approves Acalabrutinib With Bendamustine and Rituximab for Previously Untreated Mantle Cell Lymphoma

On January 16, the U.S. Food and Drug Administration (FDA) granted traditional approval to acalabrutinib (Calquence) with bendamustine and rituximab for adults with previously untreated mantle cell ly...

The ASCO Post

February 21, 2025

Can R-CHOP–Like Therapy Effectively Treat Late-Relapse DLBCL?

Late relapse of diffuse large B-cell lymphoma (DLBCL) may represent a new lymphoma arising from a common precursor cell that is essentially chemotherapy-naive. Treatment with curative intent using a s...

The ASCO Post

February 21, 2025

Salt, Sour Taste Loss Raises Mortality Risk

Research shows that adults experiencing perceived taste loss face a higher risk of mortality, particularly when the ability to detect salt and sourness declines.

Conexiant

February 20, 2025

18-Year Neuroblastoma Remission in a Patient After GD2 CAR T-Cell Therapy

"She has never required any other therapy and is likely the longest-surviving patient with cancer who received [CAR T-cell] therapy."

Conexiant